| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Inflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval: | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 40-9184 Revised – August 2015 Rx Only Prescribing Information | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Inflamation Reduction Pack These highlights do not include all the information needed to use Inflammation Reduction Pack safely and effectively.see full prescribing information for Inflammation Reduction Pack Inflammation Reduction Pack (Inflammation Reduction Pack) KIT for use. Initial U.S. Approval: | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Extended-release Tablets | 8 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium and Misoprostol Delayed-Release Tablets | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Inflamation Reduction Pack | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | VOLTAREN | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | 1cac4fd0-70cb-2bbf-e054-00144ff8d46c | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | 1c948de4-dbbf-309a-e054-00144ff8d46c | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | 1b49b08b-8494-3f71-e054-00144ff88e88 | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets, USP 40-9184 Revised – June 2012 | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Extended-Release Tablets, USP Tablets of 100 mg Rx only Prescribing Information | 2 | |
| Diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac sodium and misoprostol delayed-release tablets | 3 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-Release Tablets USP | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets, USP 40-9184 Revised – June 2012 | 2 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg | 1 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-Release Tablets USP | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets, USP | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS, USP | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets, USP 40-8780 Revised – March 2011 | 1 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets, USP 50 mg | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC ® (diclofenac sodium/misoprostol) Tablets | 1 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | These highlights do not include all the information needed to use Voltaren® Gel safely and effectively. See full prescribing information for Voltaren® Gel. Initial U.S. Approval: 1988 | 5 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SOD DR | 4 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-Release Tablets USP | 1 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC ® (diclofenac sodium/misoprostol) Tablets | 5 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | These highlights do not include all the information needed to use Voltaren® Gel safely and effectively. See full prescribing information for Voltaren® Gel. Initial U.S. Approval: 1988 | 1 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets USP, 25 mg, 50 mg and 75 mg | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Ophthalmic Solution, 0.1% (Sterile) | 1 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | These highlights do not include all the information needed to use Voltaren® Gel safely and effectively. See full prescribing information for Voltaren® Gel. Initial U.S. Approval: 1988 | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Ophthalmic Solution, 0.1% (Sterile) | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | bd27460e-46ff-4450-a4f2-a41420c1f93d | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | 42fcf2b5-3466-4493-8a47-c4675538ece3 | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | These highlights do not include all the information needed to use Voltaren® Gel safely and effectively. See full prescribing information for Voltaren® Gel. Initial U.S. Approval: 1988 | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | These highlights do not include all the information needed to use PENNSAID ® safely and effectively. See full prescribing information for PENNSAID. PENNSAID (diclofenac sodium topical solution) 1.5% w/w is for topical use only. Initial U.S. Approval: 1988 | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Ophthalmic Solution, 0.1% (Sterile) | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-release Tablets, USP 75 mg | 1 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | These highlights do not include all the information needed to use Voltaren® Gel safely and effectively. See full prescribing information for Voltaren® Gel. Initial U.S. Approval: 1988 | 1 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC ® (diclofenac sodium/misoprostol) Tablets | 1 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | diclofenac sodium (Diclofenac Sodium) tablet | 2 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS, USP | 1 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Delayed-Release Tablets USP 25 mg, 50 mg, 75 mg | 1 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | Diclofenac Sodium Ophthalmic Solution, 0.1% | 1 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3965 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM DELAYED RELEASE (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3744 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3585 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | VOLTAREN (DICLOFENAC SODIUM) GEL [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3191 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | VOLTAREN (DICLOFENAC SODIUM) GEL [BRYANT RANCH PREPACK] | 1000 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [ACTAVIS PHARMA, INC.] | 22 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC] | 21 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [SANDOZ INC] | 15 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [ACTAVIS PHARMA, INC.] | 12 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 12 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | PENNSAID (DICLOFENAC SODIUM) SOLUTION [MALLINCKRODT, INC] | 12 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 10 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [AVKARE, INC.] | 10 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | PENNSAID (DICLOFENAC SODIUM) LIQUID [MALLINCKRODT, INC] | 10 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC.] | 8 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM AND MISOPROSTOL TABLET, FILM COATED [GREENSTONE LLC] | 7 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM DELAYED RELEASE (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [CARLSBAD TECHNOLOGY, INC.] | 7 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.] | 7 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 7 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 7 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE DICLOFENAC SODIUM TABLET, DELAYED RELEASE [RISING PHARMACEUTICALS, INC.] | 7 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | VOLTAREN (DICLOFENAC SODIUM) SOLUTION [NOVARTIS PHARMACEUTICAL CORPORATION] | 7 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM SOLUTION [ACTAVIS PHARMA, INC.] | 6 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PACK PHARMACEUTICALS, LLC] | 6 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.] | 6 | |
| diclofenac sodium | ACTIVE INGREDIENT | QTG126297Q | SOLARAZE (DICLOFENAC SODIUM) GEL [PHARMADERM, A DIVISION OF FOUGERA PHARMACEUTICALS INC.] | 6 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | VOLTAREN (DICLOFENAC SODIUM) GEL [ENDO PHARMACEUTICALS INC.] | 6 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM (DICLOFENAC SODIUM) TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM EXTENDED-RELEASE (DICLOFENAC SODIUM) TABLET, EXTENDED RELEASE [ST MARYS MEDICAL PARK PHARMACY] | 5 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED] | 5 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS ELIZABETH LLC] | 5 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 5 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | ARTHROTEC (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, FILM COATED [BRYANT RANCH PREPACK] | 4 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [BLUEPOINT LABORATORIES] | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 4 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [ST MARYS MEDICAL PARK PHARMACY] | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 4 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DERMACINRX INFLAMMATRAL PAK (DICLOFENAC SODIUM DELAYED RELEASE TABLETS, RANITIDINE TABLETS, CAPSAICIN CREAM) KIT [PURETEK CORPORATION] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC (DICLOFENAC SODIUM) SOLUTION/ DROPS [ALTAIRE PHARMACEUTICALS INC.] | 3 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM (DICLOFENAC SODIUM) SOLUTION [TELIGENT PHARMA, INC.] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM AND MISOPROSTOL TABLET, DELAYED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [MYLAN INSTITUTIONAL INC.] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 3 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [UNIT DOSE SERVICES] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | PENNSAID (DICLOFENAC SODIUM) LIQUID [UNIT DOSE SERVICES] | 3 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC (DICLOFENAC SODIUM) SOLUTION/ DROPS [AKORN, INC.] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM AND MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL) TABLET, DELAYED RELEASE [AVKARE, INC.] | 2 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM DELAYED RELEASE (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [PROFICIENT RX LP] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM GEL [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.] | 2 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM SOLUTION [APOTEX CORP.] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM SOLUTION [PADDOCK LABORATORIES, LLC] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM SOLUTION [SANDOZ INC] | 2 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [CLINICAL SOLUTIONS WHOLESALE] | 2 | |
| Diclofenac Sodium | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PROFICIENT RX LP] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, DELAYED RELEASE [REMEDYREPACK INC. ] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [PROFICIENT RX LP] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | DICLOFENAC SODIUM TABLET, FILM COATED, EXTENDED RELEASE [SANDOZ INC] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | GAPEAM BUDIBAC (AMANTADINE HCL, BACLOFEN, BUPIVACAINE HCL, CYCLOBENZAPRINE HCL, DICLOFENAC SODIUM, GABAPENTIN, AND PENTOXIFYLLINE) KIT [ALVIX LABORATORIES, LLC] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | SURPASS (DICLOFENAC SODIUM) CREAM [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| DICLOFENAC SODIUM | ACTIVE INGREDIENT | QTG126297Q | VOLTAREN (DICLOFENAC SODIUM) GEL [REMEDYREPACK INC. ] | 2 | |